S
Screening all pregnant women by culture for rectovaginal group B streptococcus (GBS) colonization at 35 to 37 weeks' gestation lowers the annual incidence of early-onset GBS disease (occurring in infants aged 0–6 days of age), according to a recent CDC report.
In fact, the incidence dropped 33% during 2003–2005, shortly after universal screening guidelines were published, when compared with 2000–2001, before the guidelines came out. But while the incidence among white infants decreased steadily during the period 2003–2005, the incidence among black infants increased 70%. And universal screening seems to have had no effect on the incidence of late-onset disease (in infants 7–89 days of age) or the incidence in pregnant women, both of which remained steady after universal screening began.
Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations-United States, 2003–2005. MMWR Morb Mortal Wkly Rep. 2007;56(28):701-705.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More